Evaluation of the performance and safety of a single-dose hyaluronic acid (Promovia hydro balance) in the treatment of non-traumatic degenerative meniscus tears
- Age between 35 and 75 years at the time of administration.
Presence of a symptomatic degenerative meniscus tear, not related to acute trauma, documented by MRI.
Positive meniscal tests.
Pain intensity NRS ≥ 4.
- Patients with traumatic meniscus tears.
Patients with a meniscal tear requiring surgical treatment (FLAP tear, radial tear, RAMP tear).
Patients with severe knee osteoarthritis.
Patients with axial deviation greater than 10°.
Innate srl
Lead sponsor
ASST Gaetano Pini-CTO
Collaborator